SCG2 and colorectal carcinoma: While a comprehensive analysis of the multi-omics data from independent cohorts was conducted and some conclusions with clinical translation prospects were obtained, the molecular mechanism of SCG2 in the prognosis, chemotherapy, and immunotherapy of CRC should be further validated in more systematic molecular experiments.